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Abstract
Background. The rising incidence of cancer and increasing number of cancer survivors place 
competing demands on specialist oncology clinics. This has led to a need to consider collaborative 
care between primary and secondary care for the long-term post-treatment care of cancer survivors.
Objective. To explore the views of breast and colorectal cancer survivors, their oncologist and GP 
about GPs taking a more active role in long-term cancer follow-up care.
Methods. Semi-structured interviews using a thematic analysis framework. Respondents were 
asked their views on the specialist hospital-based model for cancer follow-up care and their views 
on their GP taking a greater or leading role in follow-up care. Researcher triangulation was used to 
refine the coding framework and emergent themes; source triangulation and participant validation 
were used to increase credibility.
Results. Fifty-six interviews were conducted (22 patients, 16 oncologists, 18 GPs). Respondents 
highlighted the importance of GPs needing specialist cancer knowledge; the need for GPs to have 
an interest in and time for cancer follow-up care; the GPs role in providing psychosocial care; and 
the reassurance that was provided from a specialist overseeing care. A staged, shared care team 
arrangement with both GPs and specialists flexibly providing continuing care was found to be 
acceptable for most.
Conclusion. Collaborative care of cancer survivors may lessen the load on specialist oncology 
clinics. The findings suggest that building this model will require early and ongoing shared care 
processes.
Keywords:  Breast cancer, cancer care, colorectal cancer, continuity of care, family health, multidisciplinary care, primary care.
Introduction
Cancer is a leading cause of death worldwide. In Australia, it is the 
second leading cause of death and accounted for 30% of deaths in 
2016 (1). Successful treatments have resulted in a steady decrease in 
mortality, and effective screening programmes have resulted in an 
increase in incidence. Long-term cancer care involves surveillance 
for recurrence, preventive care, management of comorbidities and 
psychosocial support (2). The growing number of cancer survivors 
presents a challenge for both specialist cancer services and general 
practice and is driving a reconsideration of existing models for long-
term care. The management of chronic conditions has become an 
important part of the daily workload of general practice, making 
general practice well situated to providing continuing shared care.
Previous studies have found highly discordant views between 
patients, cancer specialists and/or GPs about the role that primary care 
should play in long-term follow-up care (3–8). Patients expected that 
cancer specialists would continue surveillance for both new and recur-
rent cancers, while their GPs would be involved in the management of 
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comorbidities and prevention. For some cancers, research has found 
that primary care follow-up had comparable outcomes (9–11). In 
Australia, patients had a strong expectation of continued care by their 
specialist but an openness to increased involvement of their GP (12).
This study investigated the attitudes and beliefs of cancer 
patients, their GPs and surgical, radiation and medical oncologists, 
regarding the long-term follow-up care for patients with no current 
evidence of disease recurrence. The aim was to explore the feasibility 
and acceptability of greater involvement of GPs in cancer follow-up 
care in Australia. While there is some information available in the lit-
erature on patient and provider preferences in cancer follow-up (12), 
this study was unique in that GPs and doctors framed their views on 
follow-up in reference to the actual patients involved in the study.
Methods
The overall study was a qualitative collective instrumental case study 
(13), which allowed for detailed investigation both within and across 
cases, informed by an interpretivist constructionist paradigm (14). This 
paper focuses on the results within groups (patients, GPs or oncologists).
The research was conducted at the Prince of Wales Hospital 
(POWH) Cancer Centre, which is a tertiary hospital service that pro-
vides specialist medical and radiation oncology services and multi-
disciplinary cancer care. In the case of early breast and colorectal 
cancer, patients are treated with permutations of surgery, chemo-
therapy and radiation therapy determined on an individual basis. 
Patients requiring combined or sequential treatments for their can-
cer are typically followed up by all specialists involved, mainly to 
manage side effects of treatment and to look for loco-regional and 
metastatic recurrence. Follow-up visits are more frequent in the first 
2 years ranging from 3 to 6 monthly then 6–12 monthly thereafter. 
Effort is made to alternate reviews between the various specialists 
involved, but this is not strictly codified.
Participants and recruitment
Purposeful sampling was employed. Oncologists from the POWH 
Cancer Centre were first invited by letter from the chief investigator. 
A letter was then sent from the consenting oncologist to their eligible 
patients asking them to participate. Patients needed to be ≥18 years 
of age, have completed active treatment for breast and/or colorectal 
cancers and have no current evidence of disease. At the completion 
of their interview, patients were asked if they agreed for their GPs to 
be invited. If they agreed, their GPs were then invited by letter. All 
participants gave full written informed consent.
Data collection
Semi-structured interviews were conducted face-to-face or by tel-
ephone according to the preference of the respondent, at a loca-
tion convenient for them, between April 2014 and August 2015. 
Respondents were asked their views on the hospital-based model for 
cancer follow-up care and about GPs taking a greater or leading role 
in follow-up care. An outline of the topics covered in the interviews 
is provided in Box 1. Interviews were audio recorded with consent.
Data analysis
Interviews were transcribed verbatim and imported into NVivo (15) 
Version 10, a programme that assists with coding and data organ-
ization. Emergent themes were identified using Braun and Clark’s 
thematic analysis framework (16). The coding framework and dom-
inant emergent themes were then reviewed by the research team to 
identify differing or additional insights or meanings, which informed 
the subsequent analysis. Although data saturation (17) was reached 
within the first few interviews within each patient, GP or oncolo-
gist group, recruiting continued until the number of individual 
GP–patient–oncologist cases was closer to the target of 20. MFH 
reviewed a random cross section of 20% of the interviews, and any 
differences in interpretation between the two coders were resolved 
by consensus. Participant validation (member checks) for a random 
cross-sectional sample of 20% of the interviews was also carried out 
(a process whereby a summary sheet of the themes and the coded 
interviews were taken back to the participants who were then asked 
to verify if the analysis had accurately represented their views).
MC was a participant in the study and was excluded from all 
stages of coding and analysis so as not to influence the findings.
Results
Participation
A total of 82 participants were approached; 67 agreed to participate, 
11 were excluded, leaving 56 participants. A breakdown of the par-
ticipant recruitment is shown in Table 1; participant demographics 
are provided in Tables 2 and 3.
Perception of general practitioners’ current role in 
cancer follow-up care
Several patients felt that GPs were generalists, and their role was 
not to deal specifically with their cancer, but their health more 
holistically:
He actually just receives the letters and the reports from my 
referring specialist and then he knows how to control my other 
problems, my blood pressure and my general health… Breast and 
colorectal cancer patient #1
A common view from GPs was they played an important role in 
holistic care, particularly in regards to psychosocial support:
…for us the follow-up is to see the impact it’s had on them not 
just physically but psychosocially, their family, their relationship, 
particularly with cancer such as breast where sometimes there is 
Box 1.  Outline of patient, general practitioner and 
oncologist interview schedule
Patients
• Experience of current follow-up strategy
• Views on hospital, specialist-led follow-up
• Views on who is the best provider to provide follow-up 
care
• Views on primary care led follow-up
• Demographics
GP/oncologist
• Role/perceived goals of cancer follow-up
• Experience of current follow-up strategy
• Views on hospital, specialist-led follow-up
• Views on who is the best provider to provide follow-up 
care
• Views on primary care led follow-up
• Demographics
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significant surgery that happens that may well impact psycho-
logical on many women and I think we can provide a good sup-
port role there… General practitioner #5
Most participants agreed that GPs currently only had a minimal role 
in cancer care. This was more by omission than design on the part of 
the cancer specialists and/or patients:
…[the GP] has given me the referral and that’s it…and maybe 
after the specialist give one letter to her to see, you know 
my history or something he said, no more. Colorectal cancer 
patient #2
So I wouldn’t say the GPs at the moment are particularly involved 
except for the fact that we write to them with all the information. 
So they are never kept out of the loop but they are not a part of 
the review process. Radiation oncologist #6
Several GPs stated they felt disconnected from the cancer follow-up 
care process, and feeling that there was a lack of continuity of care:
My role for many of these patients including [Name] is pretty 
non-existent really…she had her breast cancer 2012, her 
Table 1. Participant recruitment, 2014–2015
Invited Refused/away Agreed Excluded Included
Oncologist 24 7 17 No eligible patients 1 MO: BR 2, CR 3
SO: BR 3, CR 5
RO: 3
Patient 37 Refused 3 32 Ineligible 2 BR 8
Overseas 2 Too sick 1 CR 12
Not neededa 7 BR and CR 2
GP 21 Refused 3 18 0 18
BR, breast cancer; CR, colorectal cancer; MO, medical oncologist; SO, surgical oncologist; RO, radiation oncologist.
aNot needed because data saturation had been reached and enough patient–GP–oncologist cases had been recruited.
Table 2. Patient demographics, 2014–2015
Male Female Total
Cancer type
 Breast 0 8 8
 Colorectal 7 5 12
 Both 0 2 2
 Total 7 15 22
Age
 40–49 1 0 1
 50–59 0 5 5
 60–69 2 6 8
 70–79 4 3 7
 80–89 0 1 1
 Total 7 15 22
Years since diagnosis
 2 0 3 3
 3 3 4 7
 4 2 3 5
 5 1 2 3
 >5 1 3 4
 Total 7 15 22
Highest level of education
 Yr10 1 7 8
 Yr12 1 3 4
 TAFE certificate or diploma 0 1 1
 Bachelor degree 2 3 5
 Postgraduate 3 1 4
 Total 7 15 22
Main occupation
 Homemaker 0 3 3
 Administration 2 1 3
 Self-employed 0 1 1
 Professional 2 1 3
 Retired 3 9 12
 Total 7 15 22
TAFE, Technical and Further Education.
Table 3. Provider demographics, 2014–2015
Medical 
oncologist
Radiation 
oncologist
Surgeon General 
practitioner
Total
Gender
 Male 3 2 8 8 21
 Female 2 1 0 10 13
 Total 5 3 8 18 34
Age
 40–49 2 2 5 2 11
 50–59 2 0 1 11 14
 60+ 1 1 2 5 9
 Total 5 3 8 18 34
Practice type
 Public hospital 5 3 8 0 16
 Private practice 0 0 0 17 17
  50:50 public 
and private
0 0 0 1 1
 Total 5 3 8 18 34
Training
 Australia 5 3 8 14 30
 Overseas 0 0 0 4 4
 Total 5 3 8 18 34
Years practicing
 6–10 years 1 0 4 2 7
 11–20 years 2 2 1 1 6
 >20 years 2 1 3 15 21
 Total 5 3 8 18 34
Cancer specialty
 Breast 2 2 3 0 7
 Colorectal 3 1 5 0 9
 Total 5 3 8 0 16
Most recent oncology training
 <2 years 0 0 0 2 2
 3–5 years 0 0 0 1 1
 6–10 years 1 1 4 0 6
 11–20 years 2 1 2 1 6
 >20 years 2 1 2 4 9
 No training 0 0 0 10 10
 Total 5 3 8 18 34
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follow-up was with her specialist and it’s unlikely that I  will 
have any involvement in the post-acute treatment stage. She’ll 
be mostly seeing her specialist until the specialist says you don’t 
need to see me anymore, and then the follow-up, which is five 
years down the track, might be the GPs role. So we’re not really 
involved. General practitioner #13
Perception of specialist’s current role in cancer 
follow-up care
Most patients and cancer specialists felt that specialists had an impor-
tant ongoing role in surveillance of patients’ cancer and monitoring 
the long-term effects of treatment. For both breast and colorectal 
cancer patients, there was a strong bond between patient and their 
cancer specialist that some participants were reluctant to attenuate:
…you’ve often got quite a good bond after five years or so of 
treatment, of knowing one another: and to break that is always 
difficult and I think that’s why we tend to follow patients more 
than we need to amongst other reasons… Radiation oncologist #7
Well I feel comfortable with Professor [Name] because, you know, 
from the start he was the one who really—you know, I went from 
GP who sent me to him straight and then, you know, you start 
to feel comfortable with your doctor and I feel comfortable with 
him and I would like to keep doing with him. Colorectal cancer 
patient #15
Views on general practitioners taking a greater role 
in cancer follow-up care
There were mixed views on the GP taking a greater role. Both breast 
and colorectal cancer patients valued the reassurance they got from 
a specialist looking after them especially in surveillance for cancer 
recurrence:
I take great confidence in the fact that they are specialists in their 
field. I mean [GP] is fantastic, don’t get me wrong, she’s great, but 
it does just give me incredible confidence when I  see them and 
they give me the all clear. I really do like that a lot. Breast cancer 
patient #17
However, some patients felt that GPs did not have the adequate 
training or knowledge to do cancer follow-up:
If it was so easy there would be no oncologists, all GPs would give 
treatment. But oncologist is a specialist. Breast cancer patient #9
Others stated they would be more comfortable with seeing their GPs 
for follow-up tests as long as they had adequate training:
I’m sure they would train the GPs to know what they’re looking 
for so I wouldn’t have a problem going to a GP if that was the 
case. It wouldn’t worry me. Breast cancer patient #18
Patients also recognized that certain aspects of follow-up care were 
routine and could be dealt with in general practice:
…after the first couple of sessions when I  realised…that it’s a 
blood test and a quick examination, I’d have no problem with 
that being delegated to a GP. Colorectal cancer patient #16
Although some patients and GPs stated they would be happy to 
be transferred to the care of their GP after some years, the prefer-
ence was for GPs to become involved in addition to specialists, not 
instead of.
GPs, for their part, recognized they lacked training, protocols 
and access to oncology teams. However, they were happy to be part 
of a broader multidisciplinary team providing ongoing care as long 
as they were given adequate support:
It really it has to be a joint effort between the GP and the- not 
that we’re included in the initial decision about what therapeu-
tic agents are needed to be used, but I do think we need to be 
included in the overall program. I  think that would be really, 
really good for us, and the patient. General practitioner #5
Some oncologists felt that it was possible for GPs to take on a 
role in some of the more standardized aspects of long-term cancer 
follow-up care:
I think the combination of doing check-ups like this could be very 
regimented in the sense that there is really no necessity in my 
mind, apart from obviously having colonoscopies which have to 
be done by specialists. But the process of checking up on a person, 
asking how they’re going, doing a physical examination, ordering 
a CT scan and reading or reviewing the results are not something 
that you really need, in my view, a specialist to be doing. Medical 
oncologist #13
Although having GPs take on a greater role in follow-up could alle-
viate some of the time pressures for oncologists, most oncologists 
believed that patients should still be reviewed by an oncologist, but 
less frequently:
I think people would still need some oncology follow-up but 
maybe less frequently…getting GPs involved would be helpful. 
Get them engaged a bit more. They probably should still be fol-
lowed up by a medical oncologist, I would’ve thought, but maybe 
less frequently.…I really think 12 months is appropriate. Surgical 
oncologist #9
All groups (patients, GPs and oncologists) recognized that GPs were 
time poor and that GPs would need to have an interest in cancer care 
if they were to take on a greater role in follow-up cancer care.
There was also a recognition that holistic and psychosocial care 
was important for cancer follow-up care, and this may not be ade-
quately addressed in some specialist care:
It would be nice, I suppose, to get someone to say, ‘How’s the rest 
of everything going?’…Everyone assumes that somebody else is 
doing it. Breast and colorectal cancer patient #20
I’m not sure that the hospital follow-up necessarily takes into 
account psychological issues. I think with some services at the 
time of the cancer diagnosis and initial treatment, but I  think 
in follow-up, that’s probably not followed-up. General practi-
tioner #17
…oncology specialists are not necessarily ideal in handling many 
of the non-malignant issues that might arise in somebody who’s 
been through cancer treatment; psychosocial issues, lifestyle 
issues. And so there’s kind of areas in which an oncologist would 
be very good at dealing with follow-up, and there are actually 
areas where they’re suboptimal. Medical oncologist #3
Women come in with problems having sex or men having erectile 
dysfunction…That’s what they truly want to discuss with you but 
you don’t have the time for them. You just say something like, ‘Oh 
well you don’t have your prostate cancer any more. It’s just one 
of the side effects I mentioned.’ It’s hardly satisfactory. Medical 
oncologist #12
Main factors needed for a shared care/integrated care model for can-
cer follow-up care.
Participants identified a number of requirements for shared care 
to be safe and effective. These included defining agreed roles for the 
GPs, having clear protocols and plans for care, and having systems 
that allowed for shared care as discussed below.
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Defined roles in cancer follow-up care
Specialists identified that defined roles would be needed upfront in 
accordance with patient, GP and oncologist expectations. Rather 
than being disconnected from patients during their active cancer 
treatment, GPs would be seen to have a continuing role throughout 
the process. Having this explicit would allow much greater accept-
ance by all involved:
…I think if we were to say to patients from the outset…this is the 
diagnosis, this is the treatment you’re going to have and then after 
that…your GP will be your first point of contact going forward. It 
needs clear expectation-setting from the outset rather than from 
the end of treatment…the end of treatment is a really challeng-
ing time for patients…if they knew that was something that was 
always on the cards, and they knew that there was support both 
for them and the GP in that process, they’d be more willing to 
take it up. Medical oncologist #16
Having roles defined upfront, would ensure that all parties knew 
what was expected from them. It would also help address miscon-
ceptions that GPs were not competent and had no role to play or 
that patients were being relegated to poorer quality care by being 
seen by their GPs.
Protocols for cancer follow-up care
GPs and specialists felt that specific protocols were needed to assist 
GPs to provide optimal care and to provide a safety net in case of 
recurrence or other serious event:
…to maintain levels of care delivery it would have to be set in 
some sort of a protocol, perhaps a little bit like anti-natal shared 
care. So that’s another example where you know it’s standard rou-
tine stuff and most of the time nothing happens, but occasionally 
something does happen…I think protocols give a framework and 
a guideline for best practice. So I think in the scope of that then 
I think you know general practice definitely could be intimately 
involved in the actual follow-up process. General practitioner #7
Unlike other chronic conditions, there was a strong view that specific 
cancers were infrequently seen in general practice and this meant 
that more patient-specific follow-up protocols and plans needed to 
be written by cancer specialists for each patient. Routine elements of 
follow-up care could be performed by the GP, but the overall respon-
sibility for the patient would remain with the cancer specialist who 
was expert in their tumour type and its treatment:
Well I  would see [shared care] working the same way that it 
works for, let’s say, antenatal shared care, in which there’s a pro-
tocol, some of the consultations are done with the GP, some con-
sultations are done at the hospital, and so that means that the 
patient doesn’t have to always go to the hospital for follow-up, 
it could be done in the GP setting organising tumour markers for 
instance or CTs if they are required at different stages of their 
follow-up care…a protocol should be started, even with forms or 
some kind of template that we could fill out and say okay this has 
been sent to the hospital now, the patient’s had, let’s say, two more 
markers or whatever and a colonoscopy or, look, I don’t know, 
and then if that gets sent to the specialist or the oncology depart-
ment so somebody would review that and say, yes fine. General 
practitioner #11
Specialists retaining ownership or responsibility for their patients 
also ensured that patients were readily able to be sent directly into 
secondary care without having to go back through the hospital 
emergency department:
…they would need a very clear path that if something came up 
that they could immediately then call back on the specialist ser-
vice. Medical oncologist #13
Improved information sharing, in real time
The lag time in GPs receiving information on a patient after a spe-
cialist visit was identified as an issue by many. Improved information 
sharing was identified as a crucial component to the model:
A lot of support in terms of electronic support systems and 
information systems so that information transfer—people could 
be reassured that information was being transferred effectively 
and accurately between GP practices and specialist practices, and 
access to that information for the patient themselves and the nurs-
ing leader. Medical oncologist #13
This has implications for electronic health record capabilities and 
remote access to hospital records by both specialists and GPs:
I think if we can link that up where the specialist will have access 
to the hospital system, you know from their own private personal 
computers or computers in their rooms, and then also those infor-
mation can then be passed on to the GPs in their rooms networked 
computer, that would be fantastic. Surgical oncologist #15
Discussion
An integrated shared care model has the potential to streamline the 
follow-up process while taking the burden off the hospital system; 
prevent duplication of services; increase GPs exposure to cancer 
cases and correct misconceptions about GPs not needing to be part 
of cancer follow-up care or currently playing a role; and provide 
continuity of care for patients, including psychosocial care and man-
agement of comorbidities, while reassuring patients that a specialist 
is overseeing their care.
A unique feature of this study was that patients, specialists and 
GPs were linked together, which meant that their discussion of 
follow-up cancer care and shared care was not abstract but very 
concrete, taking into consideration the capacity and interpersonal 
dynamics of the real relationships.
A key finding of this study was that cancer patients, their GPs 
and cancer specialists were mostly comfortable with the idea of GPs 
being more involved in cancer follow-up care due to the value of the 
psychosocial and holistic care that GPs provided, but less so with 
the total transfer of care to general practice. This was because of 
the reassurance that was provided by having a specialist oversee-
ing patient care, the specific follow-up surveillance and monitoring 
required for each patient, concerns with the quality of cancer knowl-
edge and training of GPs, time pressures GPs face in general practice 
and individual GP levels of interest in cancer care. This is consist-
ent with a number of other studies of patients’ views of long-term 
follow-up care in Australia (12,18,19) and overseas (3,5,20,21).
Some GPs felt disconnected from the follow-up care process. 
Having GPs involved in a model of shared cancer care from the 
outset would increase GPs exposure to cancer patients. Other GPs 
lacked confidence in cancer care especially given the relatively small 
number of patients with a specific cancer type seen by any one GP. 
A common concern was about having specialist medical support and 
ready access for the patient back into the hospital system if needed. 
Having patient protocols and plans written by patients own oncolo-
gists would provide the reassurance of a specialist overseeing care. 
Patient, general practitioner and oncologist views regarding long-term cancer shared care 5
Downloaded from https://academic.oup.com/fampra/advance-article-abstract/doi/10.1093/fampra/cmx105/4554344
by The University of Edinburgh user
on 12 December 2017
Strong support for shared care plans initiated by cancer specialists 
for the long-term care of cancer survivors has been found in other 
Australian research (4,12).
It is recognized that cancer follow-up care requires, ‘the same 
organized, evidence- and team-based approach that is afforded other 
chronic conditions in primary care’ (22) p. 805. Fundamental to 
shared care is multidisciplinary teamwork, which assumes a higher 
level of communication and teamwork between primary and special-
ist care than is often the case (5). Effective and timely communica-
tion between GPs and cancer specialists is essential to coordination 
of cancer care (23). Where there is good communication, primary 
care providers are likely to discuss cancer survivorship issues with 
patients providing an extra layer to support (24), and improve 
the patient experience (25). Through involvement of primary care, 
cancer can be managed in conjunction with patients’ other needs 
including co-morbid conditions (26), and patient continuity of care 
and engagement can be improved (27). However, in the absence of 
this communication, many primary care providers lack confidence 
to take a significant role in the long follow-up of cancer survivors 
(5). Improved communication has been found with electronic health 
records in integrated health systems overseas (28). This highlights 
the importance of the need for improved communication channels 
between primary and secondary care and in real time, and the need 
for the development of e-platforms to share information between 
GPs and specialists to better integrate primary and secondary health 
care in Australia. Primary Health Networks are well positioned in 
Australia to work closely with cancer services, general practice and 
software providers redesign providers to redesign cancer pathways 
cancer pathways and models of care.
Limitations
This study has some limitations. Patients and oncologists were 
recruited from a single metropolitan hospital, and most patients 
had GPs who worked in the vicinity. Their views may therefore 
not reflect the views of patients and doctors in other areas or 
settings. Participants may also be individuals interested in this 
topic. However, the results were consistent with findings from 
previous research indicating (3–6,12,18) that the sample was not 
biased.
Conclusion
Although some patients and doctors are comfortable for cancer sur-
vivors to be transferred to general practice for long-term follow-up 
care, the preference is for a shared care team approach. The com-
plexity of cancer care leads to a need for a greater degree of tailoring 
or individualization of care plans and negotiation of roles than is 
necessary in the shared care of other chronic conditions. This implies 
a model of care with earlier engagement of GPs as part of the cancer 
team, GP involvement in risk assessment and care planning, and the 
development of information and communication systems to support 
this. There is an opportunity for cancer services and primary health 
networks to work closely together to develop this.
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